Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmaniaga Bhd. (7081) Financial Statements

Pharmaniaga Bhd. Financial Overview

Pharmaniaga Bhd.'s market cap is currently RM1.02B. The company's EPS TTM is RM0.06; its P/E ratio is 12.03; and it has a dividend yield of 2.23%. Pharmaniaga Bhd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueRM 3.93BRM 3.76BRM 3.40BRM 3.48BRM 4.82B
Gross ProfitRM 409.16MRM 540.49MRM 307.82MRM -209.59MRM 630.01M
Operating IncomeRM 129.65MRM 278.01MRM 694.00KRM -520.33MRM 310.33M
EBITDARM 168.94MRM 302.30MRM 22.45MRM -534.12MRM 343.78M
Net IncomeRM 48.51MRM 131.82MRM -80.16MRM -629.92MRM 172.15M
Balance Sheet
Cash & Short-Term InvestmentsRM 258.57MRM 134.84MRM 117.61MRM 52.85MRM 52.36M
Total AssetsRM 2.25BRM 1.99BRM 1.91BRM 1.85BRM 2.26B
Total DebtRM 820.03MRM 1.19BRM 1.19BRM 1.17BRM 856.86M
Net DebtRM 709.44MRM 1.04BRM 1.06BRM 1.12BRM 804.50M
Total LiabilitiesRM 1.79BRM 2.14BRM 2.19BRM 2.20BRM 1.79B
Stockholders' EquityRM 434.47MRM -171.28MRM -299.07MRM -369.69MRM 450.46M
Cash Flow
Free Cash FlowRM -47.47MRM 11.51MRM -26.71MRM -219.97MRM -109.41M
Operating Cash FlowRM -17.69MRM 42.67MRM 46.95MRM -142.34MRM -64.06M
Investing Cash FlowRM -180.24MRM -45.62MRM -67.93MRM -72.33MRM -45.56M
Financing Cash FlowRM 164.62MRM 22.10MRM 95.27MRM 220.79MRM 120.74M

Currency in MYR

Pharmaniaga Bhd. Earnings and Revenue History

-3B03B6B-20 %-10 %0 %10 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin

Pharmaniaga Bhd. Liabilities to Assets

0800M1.6B2.4B0 %50 %100 %150 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Pharmaniaga Bhd. Cash Flow

-300M-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing

Pharmaniaga Bhd. Forecast EPS vs Actual EPS

000000Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss